Unlike earlier single or dual incretin-based therapies, Retatrutide is known as a triple hormone receptor agonist, acting simultaneously on GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors
The crystal structures of un-acylated liraglutide and semaglutide are almost identical to GLP-1 (37)
Incorporating practical tips and lifestyle changes alongside GLP-1 analogue treatments can significantly enhance your weight management journey
Gradual tapering or cycling: reduce reliance on interventions as the body heals and incorporate long-term maintenance strategies such as strength training and tailored nutrition
Glucagon-like peptide-1 (GLP-1) receptor agonists are medications that have been used to treat type 2 diabetes for years
Factors such as overall health, body mass index (BMI), existing health conditions, and past weight loss attempts are taken into account